UNITY BIOTECHNOLOGY INC. news, videos and press releases - Page 4
For more news please use our advanced search feature.
UNITY BIOTECHNOLOGY INC. - More news...
UNITY BIOTECHNOLOGY INC. - More news...
- UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
- UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee
- UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
- UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
- UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
- UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
- UNITY Biotechnology Announces CFO Transition
- UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
- UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
- UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
- UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
- UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
- UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
- UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
- UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
- UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer
- UNITY Biotechnology Provides Pipeline and Business Updates
- UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference
- UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates
- UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
- UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting
- Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
- UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
- UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
- UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
- UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
- UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee
- UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline
- UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences
